9/27/2022 2:20:25 AM
AstraZeneca: Koselugo Approved In Japan For Paediatric Patients With Plexiform Neurofibromas In Neurofibromatosis Type 1
9/27/2022 2:12:46 AM
AstraZeneca Says Tezspire Approved In Japan For The Treatment Of Severe Asthma
9/23/2022 2:04:22 AM
AstraZeneca: Ultomiris Approved In Europe For Adults With Generalised Myasthenia Gravis
9/22/2022 2:05:43 AM
AstraZeneca Says Lynparza Approved In China For Ovarian Cancer
9/21/2022 2:02:05 AM
AstraZeneca Says Tezspire Approved In EU For The Treatment Of Severe Asthma
9/20/2022 2:08:42 AM
AstraZeneca Says Evusheld Approved In EU For COVID-19 Treatment
9/16/2022 3:21:28 AM
AstraZeneca PLC Says Danicopan Phase III Trial Meets Primary Endpoint
9/16/2022 2:07:59 AM
AstraZeneca Says Evusheld Recommended For Marketing Authorisation In EU For The Treatment Of COVID-19
9/16/2022 2:05:25 AM
AstraZeneca PLC Says Beyfortus Recommended For Approval In The EU By CHMP